Kyriazi Theo Melas is Director at Valeant Pharmaceuticals International, Inc. (VRX). They have made 3 open-market trades across 3 companies since 2009, most recently 2023-02-16.
CIK 0001216078
3 open-market purchases totalling $892K since 2009, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.